Skip to content
Agentic 10-K

Olema Pharmaceuticals, Inc.OLMA

AI agent disclosures in SEC filings, deployment confirmed

As of 2026-08-10, Olema Pharmaceuticals, Inc. (OLMA) disclosed AI-agent language in 3 SEC filings since 2026-03-16, including 2 excerpts describing its own deployment of AI agents (source: Agentic 10-K, from SEC EDGAR).

Market cap
$569MYahoo Finance, 2026-10-21
First seen
2026-03-16
Latest filing
2026-08-10

Matching filings by quarter

012Q1 '25Q2Q3Q41Q1 '261Q21Q3Q4*
Filings* Quarter in progress

What the filings cover

Functions named

Legal & compliance

Vendors and products named

None named

Source

3 filings since 2025-01-01. All EDGAR filings (opens in a new tab)

Stage and function are keyword-rule labels, not the company’s words.

In its own words

Sentences copied from the filings, whitespace normalised.

“Our employees and personnel use artificial intelligence (AI), including generative AI, agentic AI and machine learning technologies to perform their work, and the disclosure and use of personal information in such technologies is subject to various privacy laws and other obligations.”

10-QFiled 2026-08-10Confirmed deploymentSource on sec.gov (opens in a new tab)Filing index (opens in a new tab)

“Our employees and personnel may use artificial intelligence (AI), including generative AI, agentic AI and machine learning technologies to perform their work, and the disclosure and use of personal information in generative AI technologies is subject to various privacy laws and other privacy obligations.”

10-KFiled 2026-03-16Source on sec.gov (opens in a new tab)Filing index (opens in a new tab)

All matching filings

10-Q filed 2026-08-10 Filing index (opens in a new tab)

10-QFiled 2026-08-10

Employees use AI including agentic AI and the company incorporates AI technologies into certain business aspects.

“Our employees and personnel use artificial intelligence (AI), including generative AI, agentic AI and machine learning technologies to perform their work, and the disclosure and use of personal information in such technologies is subject to various privacy laws and other obligations. We incorporate AI technologies into certain aspects of our business, and applications of AI may become important in our operations over time. There are risks involved in developing and deploying AI, and there can be no assurance that the use of AI will enhance the development of our product candidates or be beneficial to our business, including our efficiency or profitability. Our competitors or other third parties may incorporate AI into their businesses more quickly or more successfully than us, which could impair our ability to compete effectively and adversely affect our results of operations. If we are unable to effectively use AI, it could make our business less efficient and result in competitive disadvantages.”

10-Q filed 2026-05-12 Filing index (opens in a new tab)

10-QFiled 2026-05-12

Olema uses AI including agentic AI in operations and notes associated risks.

“Our employees and personnel use artificial intelligence (AI), including generative AI, agentic AI and machine learning technologies to perform their work, and the disclosure and use of personal information in such technologies is subject to various privacy laws and other obligations. We incorporate AI technologies into certain aspects of our business, and applications of AI may become important in our operations over time. There are risks involved in developing and deploying AI, and there can be no assurance that the use of AI will enhance the development of our product candidates or be beneficial to our business, including our efficiency or profitability. Our competitors or other third parties may incorporate AI into their businesses more quickly or more successfully than us, which could impair our ability to compete effectively and adversely affect our results of operations. If we are unable to effectively use AI, it could make our business less efficient and result in competitive disadvantages.”

10-K filed 2026-03-16 Filing index (opens in a new tab)

10-KFiled 2026-03-16

Employee use of generative and agentic AI may increase compliance costs, investigations, and lawsuits.

“Our employees and personnel may use artificial intelligence (AI), including generative AI, agentic AI and machine learning technologies to perform their work, and the disclosure and use of personal information in generative AI technologies is subject to various privacy laws and other privacy obligations. Governments have passed and are likely to pass additional laws regulating generative AI, such as the EU AI Act. Our use of this technology could result in additional compliance costs, regulatory investigations and actions, and consumer lawsuits. If we are unable to use generative AI, it could make our business less efficient and result in competitive disadvantages.”